Post-ischemic Stroke
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine. (NCT02422940) | Acorda Therapeutics | 2015-04-01 |
| A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets. (NCT02271217) | Acorda Therapeutics | 2014-12-01 |
Track Post-ischemic Stroke automatically
Every clearance here is in the API, with alerts when new ones post.